Here are five observations:
1. The growing number of spinal stenosis cases, as a result of aging, arthritis and heredity, will stimulate the market.
2. Surgeons often use interspinous spacers among the geriatric population.
3. In terms of end-users, orthopedic clinics lead the space, followed by hospitals and ambulatory surgery centers.
4. Developing countries will see market growth due to improvement in quality of life and more awareness about interspinous spacer products.
5. Dominant market players include:
• VertiFlex in San Clemente, Calif.
• Medyssey in Korea
• Zimmer Biomet in Warsaw, Ind.
• Depuy Synthes in Raynham, Mass.
• Precision Spine in Parsippany, N.J.
• Life Spine in Huntley, Ill.
• NuVasive in San Diego
More articles on devices:
92% of HF10 therapy trial patients report lowered back and leg pain — 5 things to know
Arlington Orthopedic Associates 1st in Texas to use NUsurface Meniscus Implant — 7 observations
Reston Hospital Center adds Mazor X to spinal surgery program — 4 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
